Loading…
Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer?
There have been dramatic changes in the approach to the axilla in women with breast cancer over the last 100 years, reflecting the evolution in our understanding of the underlying tumor biology, reduced disease burden because of early detection, and advances in all breast cancer treatment modalities...
Saved in:
Published in: | Advances in surgery (Chicago) 2012-09, Vol.46 (1), p.1-18 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3 |
container_end_page | 18 |
container_issue | 1 |
container_start_page | 1 |
container_title | Advances in surgery (Chicago) |
container_volume | 46 |
creator | Williams, Richelle T., MD Winchester, David P., MD Yao, Katharine, MD Winchester, David J., MD |
description | There have been dramatic changes in the approach to the axilla in women with breast cancer over the last 100 years, reflecting the evolution in our understanding of the underlying tumor biology, reduced disease burden because of early detection, and advances in all breast cancer treatment modalities. The approach to the axilla needs to be individualized, much like the extent of surgery for the primary tumor. Axillary dissection remains an important intervention for patients with more locally advanced disease. However, in patients with early-stage breast cancer, in whom regional recurrence is extremely low, the added benefit of an ALND has yet to be confirmed. |
doi_str_mv | 10.1016/j.yasu.2012.04.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1033159541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0065341112000127</els_id><sourcerecordid>1033159541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS1URLeFP8AB-dhLwoydeBMJtSrbliIqOBTE0XKcidZLNm7tpLD_HkdbeuiBk0ej9578vmHsLUKOgOr9Jt-ZOOUCUORQ5AD4gi2wWlYZlGV5wBYAqsxkgXjIjmLcAEipKvmKHQpRLSWIesG-_Fx7frv2U9_ya_NA3Af-1Y_72Qz8_I_rexN2adkSv3Axkh2dH_hvN675x0AmjnxlBkvh7DV72Zk-0pvH95j9uLr8vrrObr59-rw6v8msFGrMUCHWXYVGVCCtqKEpG6rbZqlQlkVaQyOUJSMtdUphVSECtNB0pSlQQSuP2ck-9y74-4niqLcuWkr_HMhPUWPqiWWdspJU7KU2-BgDdfouuG3qk0R6hqg3eoaoZ4gaCp0gJtO7x_yp2VL7ZPlHLQk-7AWUWj44CjpaR4lB60LCo1vv_p9_-sxuezc4a_pftKO48VMYEj-NOiaPvp3POF8RBSS7WMq_Ve2VOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033159541</pqid></control><display><type>article</type><title>Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer?</title><source>ScienceDirect Freedom Collection</source><creator>Williams, Richelle T., MD ; Winchester, David P., MD ; Yao, Katharine, MD ; Winchester, David J., MD</creator><creatorcontrib>Williams, Richelle T., MD ; Winchester, David P., MD ; Yao, Katharine, MD ; Winchester, David J., MD</creatorcontrib><description>There have been dramatic changes in the approach to the axilla in women with breast cancer over the last 100 years, reflecting the evolution in our understanding of the underlying tumor biology, reduced disease burden because of early detection, and advances in all breast cancer treatment modalities. The approach to the axilla needs to be individualized, much like the extent of surgery for the primary tumor. Axillary dissection remains an important intervention for patients with more locally advanced disease. However, in patients with early-stage breast cancer, in whom regional recurrence is extremely low, the added benefit of an ALND has yet to be confirmed.</description><identifier>ISSN: 0065-3411</identifier><identifier>EISSN: 1878-0555</identifier><identifier>DOI: 10.1016/j.yasu.2012.04.001</identifier><identifier>PMID: 22873029</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Axilla ; Axillary lymph node dissection ; Breast cancer ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Contraindications ; Female ; Humans ; Lymph Node Excision ; Neoplasm Staging ; Patient Selection ; Sentinel Lymph Node Biopsy ; Surgery</subject><ispartof>Advances in surgery (Chicago), 2012-09, Vol.46 (1), p.1-18</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3</citedby><cites>FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22873029$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Richelle T., MD</creatorcontrib><creatorcontrib>Winchester, David P., MD</creatorcontrib><creatorcontrib>Yao, Katharine, MD</creatorcontrib><creatorcontrib>Winchester, David J., MD</creatorcontrib><title>Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer?</title><title>Advances in surgery (Chicago)</title><addtitle>Adv Surg</addtitle><description>There have been dramatic changes in the approach to the axilla in women with breast cancer over the last 100 years, reflecting the evolution in our understanding of the underlying tumor biology, reduced disease burden because of early detection, and advances in all breast cancer treatment modalities. The approach to the axilla needs to be individualized, much like the extent of surgery for the primary tumor. Axillary dissection remains an important intervention for patients with more locally advanced disease. However, in patients with early-stage breast cancer, in whom regional recurrence is extremely low, the added benefit of an ALND has yet to be confirmed.</description><subject>Axilla</subject><subject>Axillary lymph node dissection</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Contraindications</subject><subject>Female</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Neoplasm Staging</subject><subject>Patient Selection</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Surgery</subject><issn>0065-3411</issn><issn>1878-0555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhS1URLeFP8AB-dhLwoydeBMJtSrbliIqOBTE0XKcidZLNm7tpLD_HkdbeuiBk0ej9578vmHsLUKOgOr9Jt-ZOOUCUORQ5AD4gi2wWlYZlGV5wBYAqsxkgXjIjmLcAEipKvmKHQpRLSWIesG-_Fx7frv2U9_ya_NA3Af-1Y_72Qz8_I_rexN2adkSv3Axkh2dH_hvN675x0AmjnxlBkvh7DV72Zk-0pvH95j9uLr8vrrObr59-rw6v8msFGrMUCHWXYVGVCCtqKEpG6rbZqlQlkVaQyOUJSMtdUphVSECtNB0pSlQQSuP2ck-9y74-4niqLcuWkr_HMhPUWPqiWWdspJU7KU2-BgDdfouuG3qk0R6hqg3eoaoZ4gaCp0gJtO7x_yp2VL7ZPlHLQk-7AWUWj44CjpaR4lB60LCo1vv_p9_-sxuezc4a_pftKO48VMYEj-NOiaPvp3POF8RBSS7WMq_Ve2VOA</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>Williams, Richelle T., MD</creator><creator>Winchester, David P., MD</creator><creator>Yao, Katharine, MD</creator><creator>Winchester, David J., MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer?</title><author>Williams, Richelle T., MD ; Winchester, David P., MD ; Yao, Katharine, MD ; Winchester, David J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Axilla</topic><topic>Axillary lymph node dissection</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Contraindications</topic><topic>Female</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Neoplasm Staging</topic><topic>Patient Selection</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, Richelle T., MD</creatorcontrib><creatorcontrib>Winchester, David P., MD</creatorcontrib><creatorcontrib>Yao, Katharine, MD</creatorcontrib><creatorcontrib>Winchester, David J., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in surgery (Chicago)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Richelle T., MD</au><au>Winchester, David P., MD</au><au>Yao, Katharine, MD</au><au>Winchester, David J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer?</atitle><jtitle>Advances in surgery (Chicago)</jtitle><addtitle>Adv Surg</addtitle><date>2012-09</date><risdate>2012</risdate><volume>46</volume><issue>1</issue><spage>1</spage><epage>18</epage><pages>1-18</pages><issn>0065-3411</issn><eissn>1878-0555</eissn><abstract>There have been dramatic changes in the approach to the axilla in women with breast cancer over the last 100 years, reflecting the evolution in our understanding of the underlying tumor biology, reduced disease burden because of early detection, and advances in all breast cancer treatment modalities. The approach to the axilla needs to be individualized, much like the extent of surgery for the primary tumor. Axillary dissection remains an important intervention for patients with more locally advanced disease. However, in patients with early-stage breast cancer, in whom regional recurrence is extremely low, the added benefit of an ALND has yet to be confirmed.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>22873029</pmid><doi>10.1016/j.yasu.2012.04.001</doi><tpages>18</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0065-3411 |
ispartof | Advances in surgery (Chicago), 2012-09, Vol.46 (1), p.1-18 |
issn | 0065-3411 1878-0555 |
language | eng |
recordid | cdi_proquest_miscellaneous_1033159541 |
source | ScienceDirect Freedom Collection |
subjects | Axilla Axillary lymph node dissection Breast cancer Breast Neoplasms - mortality Breast Neoplasms - pathology Contraindications Female Humans Lymph Node Excision Neoplasm Staging Patient Selection Sentinel Lymph Node Biopsy Surgery |
title | Who Should Have or Not Have an Axillary Node Dissection with Breast Cancer? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Who%20Should%20Have%20or%20Not%20Have%20an%20Axillary%20Node%20Dissection%20with%20Breast%20Cancer?&rft.jtitle=Advances%20in%20surgery%20(Chicago)&rft.au=Williams,%20Richelle%20T.,%20MD&rft.date=2012-09&rft.volume=46&rft.issue=1&rft.spage=1&rft.epage=18&rft.pages=1-18&rft.issn=0065-3411&rft.eissn=1878-0555&rft_id=info:doi/10.1016/j.yasu.2012.04.001&rft_dat=%3Cproquest_cross%3E1033159541%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-16119f81a2803c290b5be9db7613541a20b26cea3cef661881100d0bf5a4160d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1033159541&rft_id=info:pmid/22873029&rfr_iscdi=true |